A special peptide has been shown to be effective in mice, especially in suppressing cytokine storms.
Scientists have developed a potential cure for coronavirus, which protects the body from a cytokine storm. This was reported by the Rush University Medical Center (USA).
It is noted that SARS-CoV-2 binds to the ace2 enzyme to penetrate human cells and infect them. The research team developed hexapeptide (peptide with six amino acids), which prevents the virus from binding to ACE2.
It was administered to the infected mice nasally and the results were positive. The peptide has been shown to be effective in lowering fever, protecting the lungs, improving heart function, and suppressing the cytokine storm – the overreaction of the immune system to an infection that floods the bloodstream with inflammatory proteins.
Cytokine storm often occurs in COVID-19 patients and anti-inflammatory drugs are used to address this problem, which often causes suppression of the immune system. The peptide does not cause immunosuppression (suppression of the immune system).
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
The researchers stressed that the spread of the coronavirus vaccines will take months, and in some countries, years. Moreover, they cannot completely prevent the spread of the infection.
Therefore, a special medicine to reduce inflammation and treat respiratory and heart problems caused by COVID-19 will be urgently needed to better treat the disease, even in the post-vaccination era.
